20
Chemwerth Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
One of their notable products is TIAGABINE HYDROCHLORIDE, with a corresponding US DMF Number 22033.
Remarkably, this DMF maintains an Active status since its submission on September 23, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 05, 2014, and payment made on November 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II